FORM OF REGISTRATION RIGHTS AGREEMENTForm of Registration Rights Agreement • September 15th, 2016 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 14, 2016, by and among Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), the investors signatory hereto (each an “Initial Purchaser” and collectively, the “Initial Purchasers”) and (iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 7(f) hereof (collectively, the “Purchaser Permitted Transferees” and each individually a “Purchaser Permitted Transferee”).
FORM OF SECURITIES PURCHASE AGREEMENTForm of Securities Purchase Agreement • September 15th, 2016 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • Illinois
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 14, 2016 by and between CALADRIUS BIOSCIENCES, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 7 hereof.
CALADRIUS BIOSCIENCES, INC. FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 15th, 2016 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • New York
This Securities Purchase Agreement (“Agreement”) is made as of September 14, 2016 (the “Effective Date”), by and among Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto (the “Schedule of Purchasers”). Such persons and entities are hereinafter collectively referred to herein as “Purchasers” and each individually as a “Purchaser.”
CALADRIUS BIOSCIENCES, INC. FORM OF SECURITIES PURCHASE AGREEMENTOf Securities Purchase Agreement • September 15th, 2016 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • South Dakota
This Securities Purchase Agreement (“Agreement”) is made as of September 14, 2016 (the “Effective Date”), by and among Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto (the “Schedule of Purchasers”). Such persons and entities are hereinafter collectively referred to herein as “Purchasers” and each individually as a “Purchaser.”
